3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
10
Completed
7
Active not recruiting
5
Enrolling by invitation
2
Terminated
1
Suspended
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Hematologic Neoplasms
1
Interventions
Cyclophosphamide
240
Radiotherapy
216
Gemcitabine
187
Cisplatin
185
Carboplatin
182
Docetaxel
166
Bevacizumab
166
Paclitaxel
144
Rituximab
141
Capecitabine
141
pembrolizumab
139
Oxaliplatin
124
Nivolumab
124
Dexamethasone
122
Fluorouracil
113
fludarabine
103
Radiosurgery
101
Doxorubicin
99
fludarabine phosphate
96
Irinotecan
96
Etoposide
95
Lenalidomide
93
Cytarabine
91
Magnetic Resonance Spectroscopy
90
Radiation
89
Leucovorin
88
Filgrastim
88
Bortezomib
86
Cetuximab
80
Pemetrexed
79
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
OTHER
×
Health Promotion
×
Clear all
NCT04081298
2023-07-03
MiVSEEV
Fred Hutchinson Cancer Center
Phase NA
Terminated
20 enrolled
34 charts